1) Covid-19 infection fatality rates (IFR) based on antibody studies
Population-based antibody seroprevalence studies.
|Global||May 19||Most countries
|Germany||May 4||Heinsberg Cluster||<0.36¹||Study|
|Iran||May 1||Guilan province||<0.12||Study|
|USA||April 30||Santa Clara County||0.17||Study|
|Denmark||April 28||Blood donors (<70y)||0.08||Study|
|USA||April 24||Miami-Dade County||0.18||Report|
|USA||April 21||Los Angeles County||<0.20||Study|
1) The adjusted IFR is 0.278% (see page 9 of study). Note: Some of these studies are preprints.
2) Covid-19 infection fatality rates based on controlled PCR studies
Controlled PCR studies in population subgroups.
|France||May 21||Health workers||0.05||Study|
|USA||May 10||MLB employees||0.00||Report|
|France||May 10||Aircraft carrier||0.00||Report|
|USA||May 10||Aircraft carrier||0.09||Report|
|USA||May 1||Tennessee prison||0.00||Report|
|Italy²||April 28||Health workers||0.30||Study|
|USA||April 17||Boston homeless||0.00||Report|
|USA||April 17||Boston blood donors||0.00||Report|
|USA||April 13||NYC pregnant women||0.00||Study|
|Ship||March 17||Diamond Princess||0.13¹||Study|
1) Age-adjusted IFR based on US population.
3) Covid-19 infection fatality rates based on models
Covid-19 IFR based on epidemiological models or predictions. These values are often somewhat higher than the actual values based on serological antibody studies (see above).
|USA||May 20||CDC estimate||0.26¹||Study|
New York City
|China||March 30||Mainland China||0.66||Study|
|China||March 13||Wuhan city||0.12||Study|
|China||March 9||Mainland China||0.50||Study|
1) 0.4% symptomatic CFR and 35% asymptomatic cases; 2) Based on 29% prevalence and 50,000 deaths; 3) The IFR is 0.50 excluding nursing homes.
4) Additional antibody and PCR studies
These studies determine the actual prevalence of recent or current Covid-19 infections in a population or region. In most cases, they find that Covid-19 is much more widespread than previously assumed, with most people showing no or only mild symptoms.
|Czech Rep.||May 15||South Bohemia||5%||10x||Report|
|Global||May 5||< 65 years old||Study|
|Japan||May 5||Kobe City||2.7%||396x||Study|
|USA||May 2||New York State
New York City
|Spain||May 2||Health workers||11.2%||Study|
|Netherlands||April 29||Blood donors||2.7%||Study|
|France||April 23||Northern France||3%||Study|
|USA||April 19||Chelsea MA||32%||16x||Report|
|Iceland||April 14||Iceland (PCR)||0.8%||Study|
5) Median age of Covid-19 deaths per country
Half of all deaths were below, half were above the median age.
7) Hospitalization rate
Initial estimates based on Chinese data assumed a very high 20% hospitalization rate, which led to the strategy of ‘flattening the curve’ to avoid overburdening hospitals. However, population-based antibody studies (see above) have since shown that actual hospitalization rates are close to 1%, which is within the range of hospitalization rates for influenza (1 to 2%).
The US CDC found that Covid-19 hospitalization rates for people aged 65 and over are “within ranges of influenza hospitalization rates”, with rates slightly higher for people aged 18 to 64 and “much lower” (compared to influenza) for people under 18.
8) Percentage of Covid-19 deaths in care homes per country
Source: Mortality associated with COVID-19 outbreaks in care homes (LTC Covid, May 3, 2020)
Source: The Covid-19 Nursing Home Crisis by The Numbers (Freopp, May 12, 2020)
9) Development of the epidemic
Even in countries without a lockdown, the epidemic reached its peak within a few weeks of the outbreak. However, many media showed cumulative deaths per day of report (left) instead of daily deaths per day of death (right), falsely implying an ever escalating situation.
- Additional Covid-19 Antibody Serological Studies (Dr. Henrik Jarlov)
- Global Covid-19 Case Fatality Rates (Oxford Center for Evidence-Based Medicine)
- Rate of positive Covid-19 tests per country over time (SPR)